您的位置: 首页 > 农业专利 > 详情页

NAUJI PRIEŠUŽDEGIMINIAI AGENTAI
专利权人:
Resverlogix Corp.
发明人:
HANSEN, Henrik,WAGNER, Gregory,ATTWELL, Sarah,MCLURE, Kevin,KULIKOWSKI, Ewelina
申请号:
LT10714825
公开号:
LT2421533T
申请日:
2010.04.21
申请国别(地区):
LT
年份:
2018
代理人:
摘要:
Disclosed are methods of regulating interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1) and methods of treating and/or preventing cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s) by administering a naturally occurring or synthetic quinazolone derivative. The invention provides novel synthetic quinazolone compounds, as well as pharmaceutical compositions comprising those compounds.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充